Anticancer drug-induced apoptosis in human monocytic leukemic cell line U937 requires activation of endonuclease(s)

P Shrivastava1, A Sodhi, P Ranjan

  • 1School of Biotechnology, Banaras Hindu University, Varanasi, India.

Anti-Cancer Drugs
|April 11, 2000
PubMed

Insights

Anticancer drugs induce apoptosis, a programmed cell death, by triggering DNA fragmentation. Inhibiting this DNA fragmentation prevents cancer cell death, but apoptosis can still occur without it in response to other stimuli.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Apoptosis, or programmed cell death, is crucial for tumor cell elimination by anticancer agents.
  • Endonuclease-mediated internucleosomal DNA fragmentation is a widely recognized marker of apoptosis.
  • The role of DNA fragmentation in drug-induced apoptosis requires further elucidation.

Purpose of the Study:

  • To investigate the role of endonuclease-mediated DNA fragmentation in apoptosis induced by anticancer drugs.
  • To determine if DNA fragmentation is essential for anticancer drug-induced cell death.
  • To explore alternative pathways of apoptosis in the absence of DNA fragmentation.

Main Methods:

  • Induction of apoptosis in human monocytic leukemic cell line U937 using anticancer drugs (adriamycin, etoposide, cisplatin).
  • Inhibition of endonuclease activity using aurintricarboxylic acid and zinc ions.
  • Assessment of DNA fragmentation, morphological changes, nuclear alterations, and cell viability.

Main Results:

  • Anticancer drugs commonly induced endonuclease activation and oligonucleosomal DNA fragmentation.
  • Inhibition of endonuclease activity prevented apoptotic cell death, confirming DNA fragmentation's role.
  • Heat shock induced apoptosis with morphological features of cell death but without significant DNA fragmentation.

Conclusions:

  • Endonuclease-mediated DNA fragmentation is a common and essential event in apoptosis induced by anticancer drugs.
  • While DNA fragmentation is critical for drug-induced apoptosis, alternative apoptotic pathways exist, as demonstrated by heat shock induction.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...